IL15 and melanoma: Depletion of CD8+ T cells in the PDX melanoma bearing NSG‐Tg(Hu‐IL15) mice did not significantly change the tumor growth rates as compared to isotype control treated HSC‐engrafted NSG‐Tg(Hu‐IL15) mice (Figure 7B).